The Biofarma Group, a contract manufacturer of supplements, medical devices, probiotic-based drugs and cosmetics exclusively for third parties, has appointed Gianfranco Nazzi as its new CEO. He replaces Maurizio Castorina, who will keep a director’s role on the board. Nazzi brings over 20 years of international experience gained in various multinational companies in the pharmaceutical sector. Before joining…